Status:
NOT_YET_RECRUITING
Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival
Lead Sponsor:
Aga Khan University
Conditions:
Complication,Postoperative
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This randomized clinical trial aims to compare the effectiveness of heparin alone versus combination therapy of Heparin- Aspirin in improving free flap survival in patients undergoing reconstructive s...
Detailed Description
The objective of this randomized clinical trial is to evaluate the efficacy of heparin alone vs compared to combination therapy of Heparin-Aspirin in enhancing free flap survival in patients undergoin...
Eligibility Criteria
Inclusion
- Patients undergoing free flap surgery
- Age between 18 and 70 years
Exclusion
- Known hypersensitivity to heparin or aspirin
- History of bleeding disorders
- Concurrent use of other anticoagulant or antiplatelet medications
- Severe renal or hepatic impairment
- Preoperative use of aspirin that could not be stopped five days before surgery due to a higher risk of cardiac-related complications.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06512233
Start Date
January 1 2025
End Date
December 1 2025
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University
Karachi, Sindh, Pakistan, 72000